+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Bladder Cancer Drug Pipeline Update

Toll Like Receptor 4 (hToll or CD284 or TLR4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Toll Like Receptor 4 (hToll or CD284 or TLR4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 114 Pages
  • Global
From
Her2 Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Her2 Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • October 2025
  • 160 Pages
  • Global
From
RAF Proto Oncogene Serine, Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

RAF Proto Oncogene Serine, Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 117 Pages
  • Global
From
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 67 Pages
  • Global
From
Castration-Resistant Prostate Cancer (CRPC) or Hormone-Refractory Prostate Cancer (HRPCA) Therapeutics Market Report 2026 - Product Thumbnail Image

Castration-Resistant Prostate Cancer (CRPC) or Hormone-Refractory Prostate Cancer (HRPCA) Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Boston Scientific Corp (BSX) - Product Pipeline Analysis, 2025 Update - Product Thumbnail Image

Boston Scientific Corp (BSX) - Product Pipeline Analysis, 2025 Update

  • Company Profile
  • July 2025
  • 259 Pages
From
Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 53 Pages
  • Global
From
Myriad Genetics Inc (MYGN) - Product Pipeline Analysis, 2025 Update - Product Thumbnail Image

Myriad Genetics Inc (MYGN) - Product Pipeline Analysis, 2025 Update

  • Company Profile
  • June 2025
  • 77 Pages
From
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 83 Pages
  • Global
From
Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 71 Pages
  • Global
From
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 925 Pages
  • Global
From
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 137 Pages
  • Global
From
Oncolytic Virus Therapy Market Report 2026 - Product Thumbnail Image

Oncolytic Virus Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Recurrent Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Recurrent Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 45 Pages
  • Global
From
Preclinical Antibody Development Global Market Report 2026 - Product Thumbnail Image

Preclinical Antibody Development Global Market Report 2026

  • Report
  • May 2026
  • 250 Pages
  • Global
From
Natera Inc (NTRA) - Product Pipeline Analysis, 2025 Update - Product Thumbnail Image

Natera Inc (NTRA) - Product Pipeline Analysis, 2025 Update

  • Company Profile
  • June 2025
  • 62 Pages
From
Epirubicin Hydrochloride Market - Global Forecast 2025-2030 - Product Thumbnail Image

Epirubicin Hydrochloride Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Global Cell & Gene Therapy Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update - Product Thumbnail Image

Global Cell & Gene Therapy Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update

  • Report
  • August 2023
  • 1350 Pages
  • Global
From
GenomicTree Co Ltd (228760) - Product Pipeline Analysis, 2023 Update - Product Thumbnail Image

GenomicTree Co Ltd (228760) - Product Pipeline Analysis, 2023 Update

  • Company Profile
  • March 2024
  • 38 Pages
From
Abbott Diagnostics - Product Pipeline Analysis, 2022 Update - Product Thumbnail Image

Abbott Diagnostics - Product Pipeline Analysis, 2022 Update

  • Company Profile
  • February 2023
  • 335 Pages
From
Loading Indicator